News – Page 2 – Industrifonden

27.08.24 News

Industrifonden leads SEK 15 million investment round in BrainZell – pioneering the future of medicine for neurological diseases ↗

60M

17.06.24 News

Guard Therapeutics carries out a directed share issue of approximately SEK 60 million and intends to carry out a repair issue ↗

11.06.24 News

DataGuard Acquires DPOrganizer ↗

28.05.24 News

BOOST Pharma closes investment to advance cell therapy for osteogenesis imperfecta ↗

23.05.24 News

ZeroPoint Technologies Closes Funding Round for Groundbreaking Hardware-Accelerated Memory Compression Technology ↗

06.05.24 News

Founder Story: Shameek Ghosh, TrusTrace ↗

09.04.24 News

Founder Story: Karim Engelmark Cassimjee, EnginZyme ↗

26.03.24 News

Biotech company Arevo raises SEK 75 million ↗

€30

14.03.24 News

Asgard Therapeutics announces €30 million Series A financing to advance its first-in-class in vivo cell reprogramming platform for immuno-oncology ↗

13.03.24 News

SaltX secures SEK 38 million and enters partnership with ABB ↗

FAQ

27.02.24 News

FAQ: Our Investment Process ↗

18.01.24 News

TrusTrace completes $24 million growth investment to drive global expansion ↗

20.12.23 News

Grateful after a year of high activity level – reflections from our CEO ↗

21.11.23 News

Texray successfully closes SEK 45 million investment round led by Industrifonden ↗

10.10.23 News

Cellevate raises 39 million SEK in Seed Financing to accelerate their global commercial launch ↗

09.10.23 News

Industrifonden leads series A financing in Pixelgen Technologies to support commercial expansion of groundbreaking spatial proteomics platform for single cells ↗

05.10.23 News

Industrifonden invests in the rare disease company AO Pharma ↗

21.09.23 News

Fibbl raises €4 million to scale XR technologies in e-commerce, bridging the gap between physical and online stores ↗

05.09.23 News

AlixLabs secures SEK 40 million investment to advance energy-efficient semiconductor innovation ↗

29.08.23 News

Industrifonden leads SEK 15 million investment round in BrainZell – pioneering the future of medicine for neurological diseases ↗

Guard Therapeutics carries out a directed share issue of approximately SEK 60 million and intends to carry out a repair issue ↗

DataGuard Acquires DPOrganizer ↗

BOOST Pharma closes investment to advance cell therapy for osteogenesis imperfecta ↗

ZeroPoint Technologies Closes Funding Round for Groundbreaking Hardware-Accelerated Memory Compression Technology ↗

Founder Story: Shameek Ghosh, TrusTrace ↗

Founder Story: Karim Engelmark Cassimjee, EnginZyme ↗

Biotech company Arevo raises SEK 75 million ↗

Asgard Therapeutics announces €30 million Series A financing to advance its first-in-class in vivo cell reprogramming platform for immuno-oncology ↗

SaltX secures SEK 38 million and enters partnership with ABB ↗

FAQ: Our Investment Process ↗

TrusTrace completes $24 million growth investment to drive global expansion ↗

Grateful after a year of high activity level – reflections from our CEO ↗

Texray successfully closes SEK 45 million investment round led by Industrifonden ↗

Cellevate raises 39 million SEK in Seed Financing to accelerate their global commercial launch ↗

Industrifonden leads series A financing in Pixelgen Technologies to support commercial expansion of groundbreaking spatial proteomics platform for single cells ↗

Industrifonden invests in the rare disease company AO Pharma ↗

Fibbl raises €4 million to scale XR technologies in e-commerce, bridging the gap between physical and online stores ↗

AlixLabs secures SEK 40 million investment to advance energy-efficient semiconductor innovation ↗

Novatron Fusion Group closes seed round of EUR 5 million – accelerating the transformation to commercial fusion power ↗